포르테 바이오사이언시스, Inc.

SecurityFBRX / Forte Biosciences, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership337,983 shares
Latest Disclosed Value $ 8,753,760
Millennium Management Llc reports 37.01% increase in ownership of FBRX / Forte Biosciences, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 337,983 shares of Forte Biosciences, Inc. (US:FBRX) valued at $8,753,760 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 246,685 shares of Forte Biosciences, Inc.. This represents a change in shares of 37.01% during the quarter. The current value of the position is $5,583,479 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F FORTE BIOSCIENCES COM NEW 34962G208 337,983 91,298 37.01 8,754 30.12 0.0036
2026-02-17 2025-12-31 13F FORTE BIOSCIENCES COM NEW 34962G208 246,685 126,873 105.89 6,727 274.35 0.0028
2025-11-14 2025-09-30 13F FORTE BIOSCIENCES COM NEW 34962G208 119,812 47,696 66.14 1,797 92.81 0.0008
2025-08-14 2025-06-30 13F FORTE BIOSCIENCES COM NEW 34962G208 72,116 57,511 393.78 932 724.78 0.0005
2025-05-15 2025-03-31 13F FORTE BIOSCIENCES COM NEW 34962G208 14,605 14,605 113 0.0001
2020-05-14 2020-03-31 13F TOCAGEN COM 888846102 0 -96,436 -100.00 0 -100.00
2020-02-14 2019-12-31 13F TOCAGEN COM 888846102 96,436 61,179 173.52 51 121.74 0.0001
2019-11-14 2019-09-30 13F TOCAGEN COM 888846102 35,257 -8,173 -18.82 23 -92.07 0.0000
2019-08-15 2019-06-30 13F/A-1 TOCAGEN COM 888846102 43,430 43,430 290 0.0004
2019-08-14 2019-06-30 13F TOCAGEN COM 888846102 43,430 43,430 290
2019-05-14 2019-03-31 13F TOCAGEN COM 888846102 0 -30,229 -100.00 0 -100.00
2019-02-15 2018-12-31 13F/A-1 TOCAGEN COM 888846102 30,229 -53,756 -64.01 248 -81.05 0.0004
2019-02-14 2018-12-31 13F TOCAGEN COM 888846102 30,229 248
2018-11-14 2018-09-30 13F TOCAGEN COM 888846102 83,985 63,866 317.44 1,309 596.28 0.0016
2018-08-14 2018-06-30 13F TOCAGEN COM 888846102 20,119 -13,833 -40.74 188 -53.23 0.0002
2018-05-15 2018-03-31 13F TOCAGEN COM 888846102 33,952 33,952 402 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.